Do omega-3s help elderly patients with memory complaints?

  • Lancet Neurol

  • from Sarfaroj Khan
  • Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Multidomain lifestyle interventions and omega-3-polyunsaturated fatty acids (OPF), either alone or in combination, had no effect on improvement in cognitive decline during a follow-up period of 3 y.
  • An effective preventive strategy and target population remains to be determined.

Why this matters

  • No trials compared combination of specific drug and several lifestyle interventions with placebo for preventing cognitive decline.
  • The interventions evaluated are safe, inexpensive and applicable to real-world settings vs other prevention strategies like anti-amyloid drugs which are expensive to implement in clinical practice.

Study design

  • This randomized control trial evaluated 1525 participants with memory complaints (age, ≥70 y), randomly assigned to 4 interventions: multidomain+OPF, multidomain+placebo, only OPF or placebo.
  • Multidomain intervention comprised of training, physical activity, nutrition and 3 preventive consultations.
  • Funding: French Ministry of Health.

Key results

  • No difference observed in cognitive decline between placebo and multidomain +OPF (between group difference [BGD], 0.093; adjusted P, [aP]=.142), multidomain+placebo (BGD, 0.079; aP=.179) or only OPF (BGD, 0.011; aP=.812).
  • Incidence of at least 1 serious emerging adverse event was similar in multidomain+OPF (36%), multidomain+placebo (34%), OPF only (33%) and placebo (32%) groups.

Limitations

  • Participants not blinded to multidomain intervention.
  • Study not designed to evaluate intervention effects in sub-groups.